|
|
Clinical effect of Wuling Capsules on sleep disorders induced by hormone pulse therapy for nephrotic syndrome |
WANG Jiang ZHU Juqi SHI Chunzhen XIONG Qingdi YI Qinxia |
Department of Nephrology,Jiujiang Hospital of Traditional Chinese Medicine,Jiangxi Kidney Research Institute of Chinese Medicine,Jiangxi Province,Jiujiang 332000,China |
|
|
Abstract Objective To explore the treatment effect of Wuling Capsules on sleep disorders induced by hormone pulse therapy for nephrotic syndrome.Methods A total of 100 patients with sleep disorders caused by hormone shock therapy for primary nephrotic syndrome in Jiujiang Hospital of Traditional Chinese Medicine from June 2019 to June 2020 were selected as the study subjects,and they were divided into the Wuling Capsules group(50 cases)and the Estazolam group(50 cases)according to the odd and even bed numbers.The Wuling Capsules group was treated with Wuling Capsules,and the Estazolam group was given Estazolam for treatment.The efficacy and Pittsburgh sleep quality index(PSQI),treatment emergent symptom scale(TESS)and the incidence rates of adverse reactions after treatment were compared between the two groups.Results The effective rate in the Wuling Capsules group at 6 weeks of treatment was higher than that in the Estazolam group,the difference was statistically significant(P<0.05).The PSQI scores of the two groups showed decreasing trends at 6 weeks of treatment(P<0.05),and the PSQI scores at 1,3 and 6 weeks of treatment in the Wuling Capsules group were lower than those in the Estazolam group,the differences were statistically significant(P<0.05).The PSQI scores of the two groups showed significant upward trends after drug withdrawal(P<0.05),and the PSQI scores at 1,3 and 6 weeks after drug withdrawal in the Wuling Capsules group were lower than those in the Estazolam group,the differences were statistically significant(P<0.05).The TESS score in the Wuling Capsules group was lower than that in the Estazolam group,the difference was statistically significant(P<0.05).The incidence rate of adverse reactions in the Wuling Capsules group was lower than that in the Estazolam group,the difference was statistically significant(P<0.05).Conclusion Compared with Estazolam,the application of Wuling Capsules for patients with sleep disorders induced by hormone pulse therapy for nephrotic syndrome can better enhance the efficacy,improve the sleep quality and reduce the occurrence of adverse reactions.
|
|
|
|
|
[1] |
王美秋,王忍,夏正坤,等.利妥昔单抗治疗难治性激素耐药型肾病综合征的疗效和安全性[J].中华实用儿科临床杂志,2021,36(5):355-358.
|
[2] |
李冰,杨濛,翟文生.槐杞黄颗粒联合糖皮质激素治疗儿童原发性肾病综合征Meta 分析[J].中国中西医结合杂志,2019,39(2):169-177.
|
[3] |
黄琼,董陈娣,张鼎君,等.睡眠情况对慢性肾脏病患者肾功能影响的系统评价[J].海南医学院学报,2019,25(5):351-357.
|
[4] |
徐薇薇,吴爽,周冬蕊,等.交泰丸加减联合乌灵胶囊治疗失眠伴焦虑状态的临床研究[J].中西医结合心脑血管病杂志,2020,18(6):890-893.
|
[5] |
中国成人肾病综合征免疫抑制治疗专家组.中国成人肾病综合征免疫抑制治疗专家共识[J].中华肾脏病杂志,2014,30(6):467-474.
|
[6] |
中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版(精神障碍分类)[J].中华精神科杂志,2001,34(3):184-188.
|
[7] |
李显红,陈刚毅.糖尿病肾病伴睡眠障碍患者的中医体质分布与睡眠质量的相关性研究[J].广州中医药大学学报,2020,37(1):1-5.
|
[8] |
黎柱培,苗国栋,蔡玉珍,等.右佐匹克隆联合米氮平对慢性失眠障碍的疗效分析[J].国际精神病学杂志,2020,47(2):325-328,332.
|
[9] |
曾欢,谭秦湘,谭教旺,等.薄氏腹针治疗慢性肾脏病非透析期患者失眠的临床观察[J].广州中医药大学学报,2020,37(4):646-650.
|
[10] |
单梅花,乔艳丽,张国妮,等.乌灵胶囊对合并焦虑,抑郁的系统性红斑狼疮患者的影响[J].国际精神病学杂志,2020,47(1):165-167,180.
|
[11] |
邢效如,赵新春,王魁恩,等.乌灵胶囊联合帕罗西汀对广泛性焦虑症伴失眠患者的疗效及安全性[J].精神医学杂志,2016,29(4):290-292.
|
[12] |
李和军.乌灵胶囊联合帕利哌酮对精神分裂症患者血清炎症因子和神经功能的影响[J].药物评价研究,2020,43(6):1086-1090.
|
[13] |
呼亚玲.硝苯地平联合乌灵胶囊治疗原发性高血压伴焦虑症状的临床分析[J].中西医结合心脑血管病杂志,2016,14(22):2713-2714.
|
[14] |
王仕俊,栾树鑫,万洪泉,等.乌灵胶囊对脑卒中后抑郁患者临床疗效及负性情绪的影响[J].河北医学,2020,26(1):162-165.
|
[15] |
杨志华,张春美,岳红.黛力新联合乌灵胶囊治疗脑卒中后抑郁患者80 例临床分析[J].贵州医药,2020,44(1):64-66.
|
[16] |
刘卫花,黄宏敏,赵光峰.补肾安神法对轻度抑郁伴焦虑失眠患者血清5-HT 水平及SDS、SAS 积分影响研究[J].辽宁中医杂志,2019,46(2):303-306.
|
|
|
|